Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4869099_CN69099_0